v3.25.4
Segment Information (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Results of Operations, Depreciation and Amortization Expenses, Accounts Receivable and Inventory by Reportable Segments

Results of operations, depreciation and amortization expenses, accounts receivable and inventories by reportable segments for the periods indicated were as follows (in thousands):

 

Year Ended December 31, 2025

 

 

Automation Enabling Technologies

 

 

Medical Solutions

 

 

Total

 

Revenue

$

500,835

 

 

$

479,765

 

 

$

980,600

 

Cost of revenue

 

255,761

 

 

 

269,356

 

 

 

 

Amortization of purchased intangible assets

 

5,568

 

 

 

10,708

 

 

 

 

Gross profit

 

239,506

 

 

 

199,701

 

 

 

439,207

 

Research and development and engineering

 

37,805

 

 

 

58,342

 

 

 

 

Selling, general and administrative

 

76,316

 

 

 

60,034

 

 

 

 

Amortization of purchased intangible assets

 

9,772

 

 

 

17,705

 

 

 

 

Restructuring, acquisition, and related costs

 

1,082

 

 

 

12,448

 

 

 

 

Segment operating income

 

114,531

 

 

 

51,172

 

 

 

165,703

 

Unallocated costs

 

—

 

 

 

—

 

 

 

(71,691

)

Interest income (expense), net

 

—

 

 

 

—

 

 

 

(21,472

)

Other income (expense), net

 

—

 

 

 

—

 

 

 

(2,898

)

Income before income taxes

$

114,531

 

 

$

51,172

 

 

$

69,642

 

 

 

Year Ended December 31, 2024

 

 

Automation Enabling Technologies

 

 

Medical Solutions

 

 

Total

 

Revenue

$

490,620

 

 

$

458,625

 

 

$

949,245

 

Cost of revenue

 

249,364

 

 

 

260,176

 

 

 

 

Amortization of purchased intangible assets

 

6,281

 

 

 

8,492

 

 

 

 

Gross profit

 

234,975

 

 

 

189,957

 

 

 

424,932

 

Research and development and engineering

 

39,026

 

 

 

57,110

 

 

 

 

Selling, general and administrative

 

75,423

 

 

 

53,798

 

 

 

 

Amortization of purchased intangible assets

 

11,207

 

 

 

14,587

 

 

 

 

Restructuring, acquisition, and related costs

 

2,916

 

 

 

6,930

 

 

 

 

Segment operating income

 

106,403

 

 

 

57,532

 

 

 

163,935

 

Unallocated costs

 

—

 

 

 

—

 

 

 

(53,351

)

Interest income (expense), net

 

—

 

 

 

—

 

 

 

(31,489

)

Other income (expense), net

 

—

 

 

 

—

 

 

 

(29

)

Income before income taxes

$

106,403

 

 

$

57,532

 

 

$

79,066

 

 

 

Year Ended December 31, 2023

 

 

Automation Enabling Technologies

 

 

Medical Solutions

 

 

Total

 

Revenue

$

499,220

 

 

$

382,442

 

 

$

881,662

 

Cost of revenue

 

257,377

 

 

 

206,550

 

 

 

 

Amortization of purchased intangible assets

 

7,045

 

 

 

5,105

 

 

 

 

Gross profit

 

234,798

 

 

 

170,787

 

 

 

405,585

 

Research and development and engineering

 

43,024

 

 

 

49,440

 

 

 

 

Selling, general and administrative

 

72,860

 

 

 

49,227

 

 

 

 

Amortization of purchased intangible assets

 

12,942

 

 

 

7,503

 

 

 

 

Restructuring, acquisition, and related costs

 

9,691

 

 

 

1,359

 

 

 

 

Segment operating income

 

96,281

 

 

 

63,258

 

 

 

159,539

 

Unallocated costs

 

—

 

 

 

—

 

 

 

(49,043

)

Interest income (expense), net

 

—

 

 

 

—

 

 

 

(25,818

)

Other income (expense), net

 

—

 

 

 

—

 

 

 

(930

)

Income before income taxes

$

96,281

 

 

$

63,258

 

 

$

83,748

 

 

 

Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

Depreciation and Amortization Expenses

 

 

 

 

 

 

 

 

Automation Enabling Technologies

$

22,441

 

 

$

23,873

 

 

$

26,680

 

Medical Solutions

 

37,960

 

 

 

29,818

 

 

 

18,578

 

Unallocated

 

1,531

 

 

 

1,872

 

 

 

1,354

 

Total

$

61,932

 

 

$

55,563

 

 

$

46,612

 

 

 

 

December 31,

 

 

2025

 

 

2024

 

Accounts Receivable

 

 

 

 

 

Automation Enabling Technologies

$

76,685

 

 

$

70,829

 

Medical Solutions

 

108,195

 

 

 

80,197

 

Total accounts receivable

$

184,880

 

 

$

151,026

 

Inventories

 

 

 

 

 

Automation Enabling Technologies

$

110,205

 

 

$

89,009

 

Medical Solutions

 

78,079

 

 

 

55,597

 

Total inventories

$

188,284

 

 

$

144,606

 

Total segment assets

$

373,164

 

 

$

295,632

 

 

 

December 31,

 

 

2025

 

 

2024

 

Total Assets

 

 

 

 

 

Total segment assets

$

373,164

 

 

$

295,632

 

Cash and cash equivalents

 

380,871

 

 

 

113,989

 

Prepaid income taxes and income taxes receivable

 

9,382

 

 

 

8,076

 

Prepaid expenses and other current assets

 

19,184

 

 

 

15,951

 

Property, plant and equipment, net

 

118,491

 

 

 

113,135

 

Operating lease assets

 

41,697

 

 

 

42,908

 

Deferred tax assets

 

27,381

 

 

 

22,887

 

Other assets

 

8,812

 

 

 

5,991

 

Intangible assets, net

 

180,776

 

 

 

185,844

 

Goodwill

 

647,348

 

 

 

584,098

 

Total

$

1,807,106

 

 

$

1,388,511

 

Schedule of Geographic Revenue

The Company aggregates geographic revenue based on the customer location where products are shipped. Revenue from these customers is summarized for the periods indicated as follows (in thousands, except percentage data):

 

Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

 

Revenue

 

 

% of Total

 

 

Revenue

 

 

% of Total

 

 

Revenue

 

 

% of Total

 

United States

$

519,007

 

 

 

52.9

%

 

$

487,114

 

 

 

51.3

%

 

$

418,265

 

 

 

47.4

%

Germany

 

114,647

 

 

 

11.7

 

 

 

123,244

 

 

 

13.0

 

 

 

128,229

 

 

 

14.5

 

Rest of Europe

 

137,406

 

 

 

14.0

 

 

 

128,871

 

 

 

13.6

 

 

 

137,027

 

 

 

15.6

 

China

 

93,201

 

 

 

9.5

 

 

 

84,562

 

 

 

8.9

 

 

 

73,444

 

 

 

8.3

 

Rest of Asia-Pacific

 

97,034

 

 

 

9.9

 

 

 

107,054

 

 

 

11.3

 

 

 

105,350

 

 

 

12.0

 

Other

 

19,305

 

 

 

2.0

 

 

 

18,400

 

 

 

1.9

 

 

 

19,347

 

 

 

2.2

 

Total

$

980,600

 

 

 

100.0

%

 

$

949,245

 

 

 

100.0

%

 

$

881,662

 

 

 

100.0

%

 

Summary of Long-lived Assets

Long-lived assets consist of property, plant and equipment, net, and are aggregated based on the location of the assets. A summary of these long-lived assets is as follows (in thousands):

 

December 31,

 

 

2025

 

 

2024

 

United States

$

23,930

 

 

$

25,207

 

Germany

 

32,303

 

 

 

31,684

 

U.K.

 

34,420

 

 

 

34,078

 

Czech Republic

 

17,696

 

 

 

15,345

 

China

 

7,593

 

 

 

6,561

 

Rest of World

 

2,549

 

 

 

260

 

Total

$

118,491

 

 

$

113,135

 

Revenue By End Market

The Company primarily operates in two end markets: the medical market and the advanced industrial market. Revenue by end market was approximately as follows:

 

Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

Medical

 

53

%

 

 

55

%

 

 

54

%

Advanced Industrial

 

47

%

 

 

45

%

 

 

46

%

Total

 

100

%

 

 

100

%

 

 

100

%